Royal Prima PT (PRIM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.002x

Based on the latest financial reports, Royal Prima PT (PRIM) has a cash flow conversion efficiency ratio of 0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp1.86 Billion ≈ $108.71K USD) by net assets (Rp955.60 Billion ≈ $55.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Royal Prima PT fund operations to measure how many days the company can operate on defensive assets alone.

Royal Prima PT - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Royal Prima PT's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Royal Prima PT Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Royal Prima PT ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Primega Group Holdings Limited Ordinary Shares
NASDAQ:PGHL
N/A
KM Corporation
KQ:083550
-0.027x
ZOONO Group Ltd
AU:ZNO
-0.356x
Kritika Wires Limited
NSE:KRITIKA
0.011x
Frtek Co.Ltd
KQ:073540
0.029x
Farmaceutica R
RO:RMAH
N/A
Defence Therapeutics Inc.
F:DTC
1.144x
Marker Therapeutics Inc
NASDAQ:MRKR
-0.149x

Annual Cash Flow Conversion Efficiency for Royal Prima PT (2014–2024)

The table below shows the annual cash flow conversion efficiency of Royal Prima PT from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Royal Prima PT.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Rp962.38 Billion
≈ $56.39 Million
Rp46.98 Billion
≈ $2.75 Million
0.049x +125.21%
2023-12-31 Rp981.10 Billion
≈ $57.49 Million
Rp21.27 Billion
≈ $1.25 Million
0.022x -1.33%
2022-12-31 Rp982.66 Billion
≈ $57.58 Million
Rp21.59 Billion
≈ $1.27 Million
0.022x -90.97%
2021-12-31 Rp964.21 Billion
≈ $56.50 Million
Rp234.54 Billion
≈ $13.74 Million
0.243x +259.56%
2020-12-31 Rp889.35 Billion
≈ $52.11 Million
Rp60.16 Billion
≈ $3.53 Million
0.068x +1830.15%
2019-12-31 Rp851.17 Billion
≈ $49.88 Million
Rp2.98 Billion
≈ $174.81K
0.004x -91.58%
2018-12-31 Rp848.87 Billion
≈ $49.74 Million
Rp35.33 Billion
≈ $2.07 Million
0.042x -53.08%
2017-12-31 Rp250.42 Billion
≈ $14.67 Million
Rp22.22 Billion
≈ $1.30 Million
0.089x -96.16%
2016-12-31 Rp12.13 Billion
≈ $710.64K
Rp28.02 Billion
≈ $1.64 Million
2.310x +135.31%
2015-12-31 Rp722.89 Million
≈ $42.36K
Rp-4.73 Billion
≈ $-277.14K
-6.543x -274.24%
2014-12-31 Rp-2.10 Billion
≈ $-123.29K
Rp3.68 Billion
≈ $215.54K
-1.748x --

About Royal Prima PT

JK:PRIM Indonesia Medical Care Facilities
Market Cap
$17.22 Million
Rp293.91 Billion IDR
Market Cap Rank
#25582 Global
#550 in Indonesia
Share Price
Rp87.00
Change (1 day)
+4.82%
52-Week Range
Rp57.00 - Rp102.00
All Time High
Rp1640.00
About

PT Royal Prima Tbk engages in providing hospital services in Indonesia. The company operates its hospitals under the Royal Prima Medan, Royal Prima Jambi, and RSU Royal Prima Marelan names. It provides health services, such as emergency, outpatient, inpatient, laboratorium, radiology, medical rehab, pharmacy, and MCU; and general surgery, internist, VCT, ICU, cardiology, urology, haemodialysis, m… Read more